<SEC-DOCUMENT>0001213900-25-095847-index.html : 20251003 <SEC-HEADER>0001213900-25-095847.hdr.sgml : 20251003 <ACCEPTANCE-DATETIME>20251003081613 ACCESSION NUMBER: 0001213900-25-095847 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20251001 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251003 DATE AS OF CHANGE: 20251003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Onconetix, Inc. CENTRAL INDEX KEY: 0001782107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41294 FILM NUMBER: 251372128 BUSINESS ADDRESS: STREET 1: 201 E. FIFTH STREET STREET 2: SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 513-620-4101 MAIL ADDRESS: STREET 1: 201 E. FIFTH STREET STREET 2: SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Biotech, Inc. DATE OF NAME CHANGE: 20230424 FORMER COMPANY: FORMER CONFORMED NAME: Blue Water Vaccines Inc. DATE OF NAME CHANGE: 20190710 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>ea0259860-8k_onconetix.htm <DESCRIPTION>CURRENT REPORT <TEXT> Document 1 - file: ea0259860-8k_onconetix.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.1 <SEQUENCE>2 <FILENAME>ea025986001ex3-1_onconetix.htm <DESCRIPTION>CERTIFICATE OF DESIGNATIONS AUTHORIZING THE ISSUANCE OF THE SERIES E PREFERRED STOCK <TEXT> Document 2 - file: ea025986001ex3-1_onconetix.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>3 <FILENAME>ea025986001ex4-1_onconetix.htm <DESCRIPTION>FORM OF WARRANT <TEXT> Document 3 - file: ea025986001ex4-1_onconetix.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>4 <FILENAME>ea025986001ex10-1_onconetix.htm <DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT DATED OCTOBER 1, 2025 RELATING TO THE SALE OF THE SERIES E PREFERRED STOCK AND WARRANTS <TEXT> Document 4 - file: ea025986001ex10-1_onconetix.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>5 <FILENAME>ea025986001ex10-2_onconetix.htm <DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT DATED AS OF OCTOBER 1, 2025 RELATING TO THE RESALE OF THE SHARES OF COMMON STOCK UNDERLYING THE SERIES E PREFERRED STOCK AND WARRANTS <TEXT> Document 5 - file: ea025986001ex10-2_onconetix.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>6 <FILENAME>onco-20251001.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> Document 6 - file: onco-20251001.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>7 <FILENAME>onco-20251001_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> Document 7 - file: onco-20251001_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>8 <FILENAME>onco-20251001_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> Document 8 - file: onco-20251001_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: FilingSummary.html
Document 14 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>16 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>17 <FILENAME>0001213900-25-095847-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: 0001213900-25-095847-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>18 <FILENAME>ea0259860-8k_onconetix_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 18 - file: ea0259860-8k_onconetix_htm.html
Document 18 - RAW XML: ea0259860-8k_onconetix_htm.xml
</DOCUMENT> </SEC-DOCUMENT>